BUYERS GUIDE 2017
Physicians office Resource
™
The 2017 Physicians Office Resource Buyers Guide
FOR ADULTS WITH ESTABLISHED CV DISEASE * AND TYPE 2 DIABETES
A groundbreaking innovation in CV care is here
REDUCE THE RISK OF CV DEATH WITH JARDIANCE
Learn more at www . connectrx . com / jardiance INDICATION AND LIMITATIONS OF USE
†
JARDIANCE is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease .
JARDIANCE is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis .
IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS JARDIANCE should not be used in patients with a history of serious hypersensitivity to JARDIANCE or in patients with severe renal impairment , end-stage renal disease , or dialysis .
WARNINGS AND PRECAUTIONS
Hypotension JARDIANCE causes intravascular volume contraction and symptomatic hypotension may occur . Before initiating JARDIANCE , assess and correct volume status in the elderly , in patients with renal impairment , low systolic blood pressure , or on diuretics . Monitor for hypotension .
Ketoacidosis Reports of ketoacidosis , a serious lifethreatening condition requiring urgent hospitalization have been identified in patients with type 1 and type 2 diabetes mellitus receiving sodium glucose co transporter 2 ( SGLT2 ) inhibitors , including JARDIANCE . Fatal cases of ketoacidosis have been reported in patients taking JARDIANCE . Patients who present with signs and symptoms of metabolic acidosis should be assessed for ketoacidosis , even if blood glucose levels are less than 250 mg / dL . If suspected , discontinue JARDIANCE , evaluate and treat promptly .
* Patients with coronary artery disease , peripheral artery disease , or a history of myocardial infarction or stroke .
CV = cardiovascular .
Before initiating JARDIANCE , consider risk factors for ketoacidosis . Patients on JARDIANCE may require monitoring and temporary discontinuation in situations known to predispose to ketoacidosis .
2017
BUYERS GUIDE
Please see Important Safety Information and Brief Summary of Prescribing Information on adjacent pages .
LIFESAVING CV BENEFIT †
1